GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Huapont Life Science Co Ltd (SZSE:002004) » Definitions » EV-to-EBIT

Huapont Life Science Co (SZSE:002004) EV-to-EBIT : 12.12 (As of May. 16, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Huapont Life Science Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Huapont Life Science Co's Enterprise Value is ¥13,994 Mil. Huapont Life Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,155 Mil. Therefore, Huapont Life Science Co's EV-to-EBIT for today is 12.12.

The historical rank and industry rank for Huapont Life Science Co's EV-to-EBIT or its related term are showing as below:

SZSE:002004' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.39   Med: 14.7   Max: 44.09
Current: 12.12

During the past 13 years, the highest EV-to-EBIT of Huapont Life Science Co was 44.09. The lowest was 7.39. And the median was 14.70.

SZSE:002004's EV-to-EBIT is ranked better than
54.4% of 182 companies
in the Agriculture industry
Industry Median: 14.415 vs SZSE:002004: 12.12

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Huapont Life Science Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥19,837 Mil. Huapont Life Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,155 Mil. Huapont Life Science Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.82%.


Huapont Life Science Co EV-to-EBIT Historical Data

The historical data trend for Huapont Life Science Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huapont Life Science Co EV-to-EBIT Chart

Huapont Life Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.82 11.39 13.31 9.54 16.11

Huapont Life Science Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.85 13.15 15.90 16.11 17.18

Competitive Comparison of Huapont Life Science Co's EV-to-EBIT

For the Agricultural Inputs subindustry, Huapont Life Science Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huapont Life Science Co's EV-to-EBIT Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Huapont Life Science Co's EV-to-EBIT falls into.



Huapont Life Science Co EV-to-EBIT Calculation

Huapont Life Science Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=13993.900/1154.784
=12.12

Huapont Life Science Co's current Enterprise Value is ¥13,994 Mil.
Huapont Life Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,155 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huapont Life Science Co  (SZSE:002004) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Huapont Life Science Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=1154.784/19836.5174
=5.82 %

Huapont Life Science Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥19,837 Mil.
Huapont Life Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,155 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huapont Life Science Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Huapont Life Science Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Huapont Life Science Co (SZSE:002004) Business Description

Traded in Other Exchanges
N/A
Address
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.

Huapont Life Science Co (SZSE:002004) Headlines

No Headlines